We are live on
!
Find out more
EA
Emerald Advisers Portfolio holdings
AUM
$3.16B
1-Year Est. Return
109.58%
This Fund
S&P 500
This Quarter
Est. Return
+13.92%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.07B
AUM Growth
+$131M
(+6.8%)
Cap. Flow
-$8.41M
Cap. Flow
% of AUM
-0.41%
Top 10 Holdings %
Top 10 Hldgs %
17.49%
Holding
270
New
21
Increased
72
Reduced
124
Closed
24
Top Buys
| 1 |
Insmed
INSM
|
+$19.2M |
| 2 |
CHX
ChampionX
CHX
|
+$16.3M |
| 3 |
Mercury Systems
MRCY
|
+$15.2M |
| 4 |
AeroVironment
AVAV
|
+$15M |
| 5 |
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
|
+$11.6M |
Top Sells
| 1 |
Integer Holdings
ITGR
|
+$17.9M |
| 2 |
Tandem Diabetes Care
TNDM
|
+$14.3M |
| 3 |
Pacira BioSciences
PCRX
|
+$13.1M |
| 4 |
HRT
HireRight Holdings Corporation
HRT
|
+$12.9M |
| 5 |
IMGO
Imago BioSciences, Inc. Common stock
IMGO
|
+$12.8M |
Sector Composition
| 1 | Healthcare | 30.79% |
| 2 | Industrials | 15.85% |
| 3 | Consumer Discretionary | 14.25% |
| 4 | Technology | 13.06% |
| 5 | Financials | 7.82% |
Similar funds
AWE
FTUS
BFA
BP
CVA
DWP
GKWIM
BI
Emerald Advisers's Q4 2022 Portfolio in Review
As of Q4 2022, Emerald Advisers held 270 positions worth $2.07B, up 6.8% from $1.94B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Emerald Advisers's Q4 2022 filing shows 21 new, 72 increased, 124 reduced and 24 closed positions. Its largest new stake was Insmed: 994,913 shares worth $19.9M. The largest sale was Integer Holdings, an estimated $17.9M.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 31% a quarter earlier, followed by Industrials and Consumer Discretionary.
- Emerald Advisers's largest Q4 2022 buy was Insmed: 994,913 shares worth $19.9M.
- Emerald Advisers added most to Evoqua Water Technologies Corp. Common Stock in Q4 2022, an estimated $11.6M increase.
- Emerald Advisers's biggest Q4 2022 reduction was Integer Holdings, cutting an estimated $17.9M.
- Emerald Advisers fully exited Tandem Diabetes Care in Q4 2022, selling an estimated $14.3M.
- Emerald Advisers's ten largest holdings make up 17% of its $2.07B portfolio in Q4 2022.
- Emerald Advisers opened 21 new positions and closed 24 in Q4 2022.
- Emerald Advisers's portfolio value rose 6.8% quarter-over-quarter to $2.07B.
Based on Emerald Advisers's 13F filing for Q4 2022, filed 3 Feb 2023.